Valion Bio, Inc. Common Stock (VBIO) is a publicly traded the market company. As of September 17, 2026, VBIO trades at $2.23 with a market cap of $1.85M and a P/E ratio of 0.00. VBIO moved +8.17% today. Year to date, VBIO is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $2.05 to $32.50. Rallies surfaces VBIO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
The average price target is $0.00.
| Metric | Value |
|---|---|
| Price | $2.23 |
| Market Cap | $1.85M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $32.50 |
| 52-Week Low | $2.05 |
| Volume | 215.73K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
VBIO analyst coverage data. Average price target: $0.00.